Ss&H Financial Advisors, Inc. Bristol Myers Squibb CO Transaction History
Ss&H Financial Advisors, Inc.
- $343 Million
- Q4 2025
A detailed history of Ss&H Financial Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ss&H Financial Advisors, Inc. holds 69,350 shares of BMY stock, worth $3.25 Million. This represents 1.09% of its overall portfolio holdings.
Number of Shares
69,350
Previous 55,900
24.06%
Holding current value
$3.25 Million
Previous $2.52 Million
48.39%
% of portfolio
1.09%
Previous 0.78%
Shares
12 transactions
Others Institutions Holding BMY
# of Institutions
2,732Shares Held
1.58BCall Options Held
28.7MPut Options Held
28.6M-
Vanguard Group Inc Valley Forge, PA199MShares$9.3 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...